...
首页> 外文期刊>Revista de la Sociedad Espanola del Dolor >Parche de lidocaína al 5% para el tratamiento del SDRC de extremidad superior por bloqueo transcutáneo del plexo braquial: Caso Clínico
【24h】

Parche de lidocaína al 5% para el tratamiento del SDRC de extremidad superior por bloqueo transcutáneo del plexo braquial: Caso Clínico

机译:5%利多卡因贴剂治疗臂丛神经经皮阻滞所致上肢CRPS:临床病例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The complex regional pain syndrome (SDRC) it is characterized by pain, functional impotence, and tróphics alterations. The cause is a primary injury or a dysfunction of the Nervous System. SDRC-I that replaces term SRD and the SDRC-II instead of the term causalgia. Clinical case: A man of 37 years of age, that after being put under a shoulder arthroscopy began to display pain in the shoulder and important functional limitation, as well as vasomotor changes of the same extremity, reason why was diagnosed of SDRC. The patient followed several analgesic treatment by oral route, was put under numerous, sympathetic blockades and physiotherapy treatment. During these months the clinical evolution was poor, reappearing the pain in all the occasions and without displaying improvement of mobility. It was decided to initiate treatment with lidocaine patches, with this treatment the patient was able to control the pain and restaure a complete mobilization of the shoulder. Lidocaine patch is a topic analgesic developed for the treatment of neuropathic pain. It is approved in the U.S.A. for the treatment of the postherpetic neuralgia. Nevertheless, its use in other forms of neuropathic pain is being proven, like the neuropathic diabetes, chronic back pain and the miofascial pain. The SDRC is associate with an abnormal activity of the nervous system, reason why the blockade likeable by means of the anaesthetic premises widely is used. This case is similar to which we described by others authors, in patints refractary to conventional treatment and the lidocaine patch solely obtained an important control of pain and improvement the functionality of the extremity. The low risk of interactions, makes lidocaine patch an attractive option like adjuvant analgesic therapy. Being specially beneficial in patients with many drugs and in whom they receive analgesic systemic medication.
机译:复杂的区域性疼痛综合征(SDRC)以疼痛,功能性阳ence和营养改变为特征。原因是原发性损伤或神经系统功能障碍。 SDRC-I代替了术语SRD和SDRC-II,而不是因果关系。临床病例:一个37岁的男人,在接受肩关节镜检查后开始出现肩部疼痛和重要的功能局限性,以及同一肢体的血管舒缩变化,这是诊断出SDRC的原因。该患者通过口服途径进行了多种镇痛治疗,被置于许多交感神经阻滞和理疗治疗之下。在这几个月中,临床进展较差,在所有情况下都再次出现疼痛,并且活动性没有改善。决定开始用利多卡因贴剂开始治疗,通过这种治疗,患者能够控制疼痛并恢复肩膀的完全活动。利多卡因贴剂是一种用于治疗神经性疼痛的镇痛药。它在美国被批准用于治疗带状疱疹后神经痛。尽管如此,它已被证明可用于其他形式的神经性疼痛,例如神经性糖尿病,慢性背痛和面筋膜疼痛。 SDRC与神经系统的异常活动有关,之所以广泛使用可通过麻醉场所进行的阻断的原因。这种情况与我们其他作者所描述的情况相似,在常规治疗无效的患者中,利多卡因贴剂仅获得了重要的疼痛控制并改善了四肢的功能。相互作用的低风险使利多卡因贴剂成为辅助镇痛治疗等有吸引力的选择。在使用多种药物且接受镇痛性全身药物治疗的患者中特别有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号